New radiation combo aims to boost immunotherapy in hard-to-treat lung cancer
NCT ID NCT05615142
First seen May 16, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This early-phase study tests whether adding low dose radiation and focused radiation (SBRT) to immunotherapy can be safe for people with advanced non-small cell lung cancer who have run out of standard options. Nine participants will receive the combination treatment at one hospital in China. The main goal is to check for side effects and find the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.